Celiac disease affects roughly 1 in 100 people worldwide, making it one of the most common autoimmune conditions. When researchers screen large populations using blood tests for celiac-specific antibodies, about 1.4% test positive. When the stricter standard of biopsy confirmation is applied, that number drops to about 0.7%. Either way, tens of millions of people globally are living with the condition, and the majority of them don’t know it.
Global and U.S. Prevalence Numbers
A large systematic review pooling data from nearly 276,000 people found a global seroprevalence (based on blood antibody testing) of 1.4%. Among roughly 139,000 people who underwent intestinal biopsy, the confirmed prevalence was 0.7%. The gap between those two numbers reflects the fact that some people with positive blood markers haven’t yet developed the visible intestinal damage that defines a confirmed diagnosis.
In the United States specifically, data from the National Health and Nutrition Examination Survey puts prevalence at about 0.79% based on antibody testing. That translates to roughly 1 in 125 Americans showing serologic evidence of celiac autoimmunity. The disease has historically been considered most common among people of European descent, though screening studies in other populations, including parts of the Middle East, North Africa, and India, have revealed comparable rates where gluten-containing grains are dietary staples.
Incidence Is Rising Steadily
Celiac disease is not just being detected more often because of better testing. The actual incidence appears to be climbing. A meta-analysis of trends over recent decades found that new cases have been increasing by an average of 7.5% per year throughout the Western world, a pattern that has persisted from the latter half of the 20th century into the 21st. Some of that increase reflects improved awareness and more widespread screening, but studies comparing stored blood samples from decades ago with current samples suggest that the underlying rate of celiac autoimmunity has genuinely risen, pointing to environmental factors beyond genetics.
Who Gets Celiac Disease
Among adults, celiac disease is more commonly diagnosed in women, with a male-to-female ratio of roughly 0.8 to 1. Interestingly, this pattern flips in children: boys are diagnosed more often than girls, with a ratio of about 1.3 to 1. The average age at diagnosis for adults is in the late 30s, though the disease can appear at any point after gluten is introduced into the diet.
Genetics play a gatekeeping role. Nearly all people with celiac disease (over 98%) carry one of two specific immune system gene variants known as HLA-DQ2 or HLA-DQ8. But carrying these genes doesn’t mean you’ll develop the disease. Between 20% and 40% of the general population carries one or both of these markers, and only a small fraction of them ever develop celiac disease. The genes are necessary but not sufficient on their own.
First-Degree Relatives
If you have a parent, sibling, or child with celiac disease, your risk jumps significantly. Screening studies have found that about 4.8% of first-degree relatives have biopsy-confirmed celiac disease, and when antibody testing alone is used, roughly 9.5% show signs of celiac autoimmunity. Among relatives of celiac patients, the rate of carrying HLA-DQ2 or HLA-DQ8 genes rises to nearly 90%, compared to about 40% to 55% in the general population without a family connection.
People With Type 1 Diabetes
Type 1 diabetes and celiac disease share genetic risk factors, and the overlap is striking. Depending on the population studied, between 1% and 8% of people with type 1 diabetes also have celiac disease, roughly 20 times the rate seen in the general population. In some Middle Eastern studies, the co-occurrence climbs as high as 15%. Most guidelines now recommend screening people with type 1 diabetes for celiac disease, even in the absence of digestive symptoms.
The Massive Diagnostic Gap
Perhaps the most important number in celiac disease prevalence is this one: more than 80% of people who have the condition have never been diagnosed. That means for every person eating a gluten-free diet because of a confirmed diagnosis, four or more others are walking around with ongoing intestinal damage and no idea why they feel the way they do.
Several factors fuel this gap. Celiac disease doesn’t always look the way people expect. Classic symptoms like chronic diarrhea, bloating, and weight loss are common in children, but adults frequently present with subtler problems: iron deficiency that doesn’t respond to supplements, unexplained fatigue, joint pain, recurrent mouth ulcers, or even no digestive symptoms at all. These nonclassical presentations are easily attributed to other conditions or dismissed entirely.
Testing itself adds complexity. Blood antibody tests are the standard first step, but they aren’t perfect. In one hospital-based study, about 19% of patients with biopsy-confirmed celiac disease had completely negative blood antibody results, and another 23% had equivocal results. This means relying on blood tests alone will miss a meaningful number of cases. Intestinal biopsy remains the gold standard for confirmation, though guidelines in some countries now allow diagnosis without biopsy in children with very high antibody levels and clear symptoms.
Why Prevalence Numbers Vary So Much
You’ll see celiac disease prevalence quoted anywhere from 0.5% to 2% depending on the source, and the variation comes down to methodology. Studies using only biopsy-confirmed cases report lower numbers (around 0.7% globally). Studies using blood antibody screening report higher numbers (around 1.4%). Population-based screening studies, which test everyone regardless of symptoms, consistently find higher rates than studies that only count people who sought medical care.
Geography matters too, but not always in the ways you’d expect. Celiac disease was long considered a European condition, but that reflected where researchers were looking rather than where the disease existed. Screening studies in countries like India, Iran, and parts of sub-Saharan Africa have revealed substantial prevalence wherever wheat, barley, or rye are significant parts of the local diet. In populations that traditionally eat very little gluten, such as those relying primarily on rice or corn, celiac disease is predictably rare regardless of genetic susceptibility.